A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis
Am J Hematol
.
2018 Feb;93(2):E33-E35.
doi: 10.1002/ajh.24956.
Epub 2017 Nov 17.
Authors
Paola Minetto
1
,
Fabio Guolo
1
,
Marino Clavio
1
,
Annalisa Kunkl
2
,
Nicoletta Colombo
1
,
Enrico Carminati
1
,
Livia Giannoni
1
,
Filippo Ballerini
1
,
Roberto Massimo Lemoli
1
,
Marco Gobbi
1
,
Maurizio Miglino
1
Affiliations
1
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Policlinico San Martino, IRCCS per l'Oncologia, Genoa, Italy.
2
Clinical Flow Cytometry Unit, Anatomic Pathology, Policlinico San Martino, IRCCS per l'Oncologia, Genoa, Italy.
PMID:
29080220
DOI:
10.1002/ajh.24956
No abstract available
Publication types
Letter
MeSH terms
Dendritic Cells / pathology*
Humans
Leukemia, Myeloid, Acute / diagnosis*
Mutation*
Nuclear Proteins / genetics*
Nucleophosmin
Phenotype
Prognosis
Substances
NPM1 protein, human
Nuclear Proteins
Nucleophosmin